Mallinckrodt to buy Questcor Pharma for about $5.6 billion

(Reuters) - Specialty pharmaceuticals company Mallinckrodt Plc agreed to buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its multiple sclerosis drug, Acthar Gel. Questcor's shareholders will receive $30 in cash and 0.897 Mallinckrodt shares for each Questcor share held, for a total value of about $86.10 per Questcor share, the companies said in a joint statement. (Reporting by Esha Dey in Bangalore; Editing by Kirti Pandey)



via Health News Headlines - Yahoo News http://ift.tt/PENB3K